Cargando…

Mast Cell Targeted Chimeric Toxin Can Be Developed as an Adjunctive Therapy in Colon Cancer Treatment

The association of colitis with colorectal cancer has become increasingly clear with mast cells being identified as important inflammatory cells in the process. In view of the relationship between mast cells and cancer, we studied the effect and mechanisms of mast cells in the development of colon c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shan, Li, Linmei, Shi, Renren, Liu, Xueting, Zhang, Junyan, Zou, Zehong, Hao, Zhuofang, Tao, Ailin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810216/
https://www.ncbi.nlm.nih.gov/pubmed/26978404
http://dx.doi.org/10.3390/toxins8030071
_version_ 1782423752667037696
author Wang, Shan
Li, Linmei
Shi, Renren
Liu, Xueting
Zhang, Junyan
Zou, Zehong
Hao, Zhuofang
Tao, Ailin
author_facet Wang, Shan
Li, Linmei
Shi, Renren
Liu, Xueting
Zhang, Junyan
Zou, Zehong
Hao, Zhuofang
Tao, Ailin
author_sort Wang, Shan
collection PubMed
description The association of colitis with colorectal cancer has become increasingly clear with mast cells being identified as important inflammatory cells in the process. In view of the relationship between mast cells and cancer, we studied the effect and mechanisms of mast cells in the development of colon cancer. Functional and mechanistic insights were gained from ex vivo and in vivo studies of cell interactions between mast cells and CT26 cells. Further evidence was reversely obtained in studies of mast cell targeted Fcε-PE40 chimeric toxin. Experiments revealed mast cells could induce colon tumor cell proliferation and invasion. Cancer progression was found to be related to the density of mast cells in colonic submucosa. The activation of MAPK, Rho-GTPase, and STAT pathways in colon cancer cells was triggered by mast cells during cell-to-cell interaction. Lastly, using an Fcε-PE40 chimeric toxin we constructed, we confirmed the promoting effect of mast cells in development of colon cancer. Mast cells are a promoting factor of colon cancer and thus also a potential therapeutic target. The Fcε-PE40 chimeric toxin targeting mast cells could effectively prevent colon cancer in vitro and in vivo. Consequently, these data may demonstrate a novel immunotherapeutic approach for the treatment of tumors.
format Online
Article
Text
id pubmed-4810216
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-48102162016-04-04 Mast Cell Targeted Chimeric Toxin Can Be Developed as an Adjunctive Therapy in Colon Cancer Treatment Wang, Shan Li, Linmei Shi, Renren Liu, Xueting Zhang, Junyan Zou, Zehong Hao, Zhuofang Tao, Ailin Toxins (Basel) Article The association of colitis with colorectal cancer has become increasingly clear with mast cells being identified as important inflammatory cells in the process. In view of the relationship between mast cells and cancer, we studied the effect and mechanisms of mast cells in the development of colon cancer. Functional and mechanistic insights were gained from ex vivo and in vivo studies of cell interactions between mast cells and CT26 cells. Further evidence was reversely obtained in studies of mast cell targeted Fcε-PE40 chimeric toxin. Experiments revealed mast cells could induce colon tumor cell proliferation and invasion. Cancer progression was found to be related to the density of mast cells in colonic submucosa. The activation of MAPK, Rho-GTPase, and STAT pathways in colon cancer cells was triggered by mast cells during cell-to-cell interaction. Lastly, using an Fcε-PE40 chimeric toxin we constructed, we confirmed the promoting effect of mast cells in development of colon cancer. Mast cells are a promoting factor of colon cancer and thus also a potential therapeutic target. The Fcε-PE40 chimeric toxin targeting mast cells could effectively prevent colon cancer in vitro and in vivo. Consequently, these data may demonstrate a novel immunotherapeutic approach for the treatment of tumors. MDPI 2016-03-11 /pmc/articles/PMC4810216/ /pubmed/26978404 http://dx.doi.org/10.3390/toxins8030071 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wang, Shan
Li, Linmei
Shi, Renren
Liu, Xueting
Zhang, Junyan
Zou, Zehong
Hao, Zhuofang
Tao, Ailin
Mast Cell Targeted Chimeric Toxin Can Be Developed as an Adjunctive Therapy in Colon Cancer Treatment
title Mast Cell Targeted Chimeric Toxin Can Be Developed as an Adjunctive Therapy in Colon Cancer Treatment
title_full Mast Cell Targeted Chimeric Toxin Can Be Developed as an Adjunctive Therapy in Colon Cancer Treatment
title_fullStr Mast Cell Targeted Chimeric Toxin Can Be Developed as an Adjunctive Therapy in Colon Cancer Treatment
title_full_unstemmed Mast Cell Targeted Chimeric Toxin Can Be Developed as an Adjunctive Therapy in Colon Cancer Treatment
title_short Mast Cell Targeted Chimeric Toxin Can Be Developed as an Adjunctive Therapy in Colon Cancer Treatment
title_sort mast cell targeted chimeric toxin can be developed as an adjunctive therapy in colon cancer treatment
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810216/
https://www.ncbi.nlm.nih.gov/pubmed/26978404
http://dx.doi.org/10.3390/toxins8030071
work_keys_str_mv AT wangshan mastcelltargetedchimerictoxincanbedevelopedasanadjunctivetherapyincoloncancertreatment
AT lilinmei mastcelltargetedchimerictoxincanbedevelopedasanadjunctivetherapyincoloncancertreatment
AT shirenren mastcelltargetedchimerictoxincanbedevelopedasanadjunctivetherapyincoloncancertreatment
AT liuxueting mastcelltargetedchimerictoxincanbedevelopedasanadjunctivetherapyincoloncancertreatment
AT zhangjunyan mastcelltargetedchimerictoxincanbedevelopedasanadjunctivetherapyincoloncancertreatment
AT zouzehong mastcelltargetedchimerictoxincanbedevelopedasanadjunctivetherapyincoloncancertreatment
AT haozhuofang mastcelltargetedchimerictoxincanbedevelopedasanadjunctivetherapyincoloncancertreatment
AT taoailin mastcelltargetedchimerictoxincanbedevelopedasanadjunctivetherapyincoloncancertreatment